Key Decisions and Appointments

1. Appointment of Additional Director

  • The Board approved the appointment of Dr. Swetha (DIN: 01728751) as Additional Director in the category of Non-Executive, Non-Independent Director, effective May 25, 2026.
  • The appointment is made pursuant to Section 161 of the Companies Act, 2013 and is subject to approval by shareholders.
  • Dr. Swetha is liable to retire by rotation.
  • Brief Profile: Dr. Swetha is a renowned industrialist, educationist, and philanthropist with over a decade of experience across multiple Indian states. She holds an M.B.B.S. from Madras Medical College, Chennai; an M.B.A. from Bharath University; and a Ph.D. from Bharath Institute of Higher Education & Research, Chennai. She currently serves as Managing Director of diversified businesses and educational institutions across healthcare, hospitality, education, power generation, pharmaceuticals, media, and infrastructure. She is related to Mr. Sundeep Anand Jegath Rekshagan, Promoter of the Company.
  • Dr. Swetha is not debarred from holding director position in any listed company by SEBI or any other authority.

2. Reappointment of Internal Auditor

  • Based on the recommendation of the Audit Committee, the Board re-appointed M/s. B. Thiagarajan & Co., Chartered Accountants, Chennai as Internal Auditor of the Company.
  • Term: For two financial years (2026-2027 and 2027-2028), effective May 25, 2026.
  • Brief Profile: M/s. B. Thiagarajan & Co. is a reputed CA firm with over 50 years of experience in audit and assurance, taxation compliance, and business advisory.

3. Resignation of Director

  • Mr. S Baskaran (DIN: 01918525) tendered his resignation from the position of Non-Executive Non-Independent Director, effective May 25, 2026.
  • Reason for resignation: Preoccupation and other personal commitments.
  • Mr. Baskaran confirmed no other material reasons for his resignation and expressed continued goodwill and support for the Company.

Financial Impact

No direct financial impact quantified in the disclosure. The changes relate to board composition and internal audit appointments.